Gut-derived peptide hormone receptor expression in the developing mouse hypothalamus

Objective In adult organisms, a number of receptors have been identified which modulate metabolic processes related to peptides derived from the intestinal tract. These receptors play significant roles in glucose homeostasis, food intake and energy balance. Here we assess these classical metabolic receptors and their expression as well as their potential role in early development of hypothalamic neuronal circuits. Methods Chow-fed C57BL6/N female mice were mated and hypothalamic tissue was collected from offspring across postnatal development (postnatal day 7–21). Subsequent qPCR and Western Blot analyses were used to determine mRNA and protein changes in gut-derived peptide hormone receptors. Correlations to body weight, blood glucose and circulating leptin levels were analyzed. Results We describe the gene expression and dynamic protein regulation of key gut-derived peptide hormone receptors in the early postnatal period of the mouse brain. Specifically, we show changes to Gastric inhibitory polypeptide receptor (GIPR), glucagon-like peptide 1 receptor (GLP1R), and cholecystokinin receptor 2 (CCK2R) in the developing hypothalamus. The changes to GIPR and InsR seem to be strongly negatively correlated with body weight. Conclusions This comprehensive analysis underscores the need to understand the roles of maternal-derived circulating gut hormones and their direct effect on offspring brain development.

[1]  Chathura Gunasekara,et al.  Sex-specific epigenetic development in the mouse hypothalamic arcuate nucleus pinpoints human genomic regions associated with body mass index , 2022, Science advances.

[2]  Ż. Kimber-Trojnar,et al.  Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus , 2022, International journal of molecular sciences.

[3]  Zeyun Li,et al.  A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes , 2022, British journal of pharmacology.

[4]  G. Atella,et al.  The model of litter size reduction induces long‐term disruption of the gut‐brain axis: An explanation for the hyperphagia of Wistar rats of both sexes , 2022, Physiological reports.

[5]  P. Nathanielsz,et al.  Dipeptidyl peptidase IV inhibition delays developmental programming of obesity and metabolic disease in male offspring of obese mothers , 2022, Journal of Developmental Origins of Health and Disease.

[6]  C. Kappen,et al.  Effects of Maternal Diabetes and Diet on Gene Expression in the Murine Placenta , 2022, Genes.

[7]  H. Preissl,et al.  Incretin hypersecretion in gestational diabetes mellitus , 2021, medRxiv.

[8]  Mei Liu,et al.  GIP-GIPR promotes neurite outgrowth of cortical neurons in Akt dependent manner. , 2020, Biochemical and biophysical research communications.

[9]  Ming Li,et al.  Maternal sitagliptin treatment attenuates offspring glucose metabolism and intestinal proinflammatory cytokines IL-6 and TNF-α expression in male rats , 2020, PeerJ.

[10]  D. Drucker,et al.  Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease , 2020, Molecular metabolism.

[11]  A. Giusti-Paiva,et al.  Neonatal overnutrition programming impairs cholecystokinin effects in adult male rats. , 2020, The Journal of nutritional biochemistry.

[12]  M. Selbach,et al.  mRNAs, proteins and the emerging principles of gene expression control , 2020, Nature Reviews Genetics.

[13]  Yao Li,et al.  Sitagliptin improves functional recovery via GLP‐1R‐induced anti‐apoptosis and facilitation of axonal regeneration after spinal cord injury , 2020, Journal of cellular and molecular medicine.

[14]  J. Holst,et al.  GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists , 2020, The Journal of clinical endocrinology and metabolism.

[15]  A. Galli,et al.  A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain , 2020, The Journal of comparative neurology.

[16]  Q. Zeng,et al.  Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes , 2020, Frontiers in Endocrinology.

[17]  K. Elkind-Hirsch,et al.  Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study. , 2020, Journal of diabetes and its complications.

[18]  Bing Yao,et al.  Developmental changes and sex differences in DNA methylation and demethylation in hypothalamic regions of the mouse brain , 2020, Epigenetics.

[19]  S. Omar,et al.  Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study , 2020, Journal of diabetes research.

[20]  Chengcong Chen,et al.  The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[21]  G. Yeo,et al.  Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake , 2019, Cell metabolism.

[22]  K. Conrad,et al.  Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor TAS2R14: trophoblast expression and signaling. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  V. Gurevich,et al.  GPCR Signaling Regulation: The Role of GRKs and Arrestins , 2019, Front. Pharmacol..

[24]  F. Reimann,et al.  Function and mechanisms of enteroendocrine cells and gut hormones in metabolism , 2019, Nature Reviews Endocrinology.

[25]  D. Bates,et al.  Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models , 2018, Science Translational Medicine.

[26]  James E. Richards,et al.  Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food , 2018, Diabetes.

[27]  N. Irwin,et al.  Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential , 2018, Biochemical pharmacology.

[28]  D. Drucker Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. , 2018, Cell metabolism.

[29]  Casper Bo Jensen,et al.  Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization , 2018, Endocrinology.

[30]  David N. Groff,et al.  Neonatal GLP1R activation limits adult adiposity by durably altering hypothalamic architecture , 2017, Molecular metabolism.

[31]  Simon C. Cork,et al.  Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain , 2015, Molecular metabolism.

[32]  N. Šestan,et al.  Functional Synergy between Cholecystokinin Receptors CCKAR and CCKBR in Mammalian Brain Development , 2015, PloS one.

[33]  T. Hansen,et al.  Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy. , 2015, The Journal of clinical endocrinology and metabolism.

[34]  K. Rácz,et al.  Cord serum dipeptidyl‐peptidase 4 activity in gestational diabetes , 2015, European journal of clinical investigation.

[35]  M. Sander,et al.  Postnatal β-Cell Proliferation and Mass Expansion Is Dependent on the Transcription Factor Nkx6.1 , 2014, Diabetes.

[36]  D. Drucker,et al.  Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors , 2014, Endocrine reviews.

[37]  B. Kuster,et al.  Mass-spectrometry-based draft of the human proteome , 2014, Nature.

[38]  Mingfeng Li,et al.  Laminar and temporal expression dynamics of coding and noncoding RNAs in the mouse neocortex. , 2014, Cell reports.

[39]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.

[40]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics* , 2013, Molecular & Cellular Proteomics.

[41]  N. Murakami,et al.  Changes in mRNA expression of arcuate nucleus appetite-regulating peptides during lactation in rats , 2013, Journal of molecular endocrinology.

[42]  N. Irwin,et al.  Alterations of Glucose-Dependent Insulinotropic Polypeptide and Expression of Genes Involved in Mammary Gland and Adipose Tissue Lipid Metabolism during Pregnancy and Lactation , 2013, PloS one.

[43]  Yuichiro Yamada,et al.  Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor‐deficient mice , 2013, Journal of diabetes investigation.

[44]  T. Vilsbøll,et al.  Reduced postprandial GLP‐1 responses in women with gestational diabetes mellitus , 2013, Diabetes, obesity & metabolism.

[45]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[46]  M. Ikeda,et al.  Functional Compensation between Cholecystokinin-1 and -2 Receptors in Murine Paraventricular Nucleus Neurons* , 2012, The Journal of Biological Chemistry.

[47]  A. C. Magalhães,et al.  Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins , 2012, British journal of pharmacology.

[48]  S. Bouret,et al.  Distinct Roles for Specific Leptin Receptor Signals in the Development of Hypothalamic Feeding Circuits , 2012, The Journal of Neuroscience.

[49]  R. Parenti,et al.  Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival. , 2011, Central nervous system agents in medicinal chemistry.

[50]  C. Hölscher,et al.  Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. , 2011, Journal of neurophysiology.

[51]  K. Nakashima,et al.  Epigenetic regulation in neural stem cell differentiation , 2010, Development, growth & differentiation.

[52]  T. Matsui,et al.  Cholecystokinin Facilitates Glutamate Release by Increasing the Number of Readily Releasable Vesicles and Releasing Probability , 2010, The Journal of Neuroscience.

[53]  S. Chu,et al.  Prepregnancy Obesity Prevalence in the United States, 2004–2005 , 2009, Maternal and Child Health Journal.

[54]  M. Horowitz,et al.  Role of cholecystokinin in appetite control and body weight regulation , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[55]  S. Bouret,et al.  Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding , 2004, Science.

[56]  S. Bouret,et al.  Formation of Projection Pathways from the Arcuate Nucleus of the Hypothalamus to Hypothalamic Regions Implicated in the Neural Control of Feeding Behavior in Mice , 2004, The Journal of Neuroscience.

[57]  N. Greig,et al.  A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[58]  W. Rohde,et al.  Cholecystokinin-8S levels in discrete hypothalamic nuclei of weanling rats exposed to maternal protein malnutrition , 1999, Regulatory Peptides.

[59]  J. Flier,et al.  Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. , 1998, The Journal of clinical investigation.

[60]  S. Vigna,et al.  Gastric inhibitory polypeptide (GIP) binding sites in rat brain , 1994, Peptides.

[61]  M. Brownstein,et al.  Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. , 1993, Endocrinology.

[62]  E. Van Obberghen,et al.  Expression of IGF‐I and insulin receptor genes in the rat central nervous system: A developmental, regional, and cellular analysis , 1991, Journal of neuroscience research.

[63]  K. Bremme,et al.  Plasma Levels of Cholecystokinin and Gastrin During the Menstrual Cycle and Pregnancy , 1990, Acta obstetricia et gynecologica Scandinavica.

[64]  A. Trzeciak,et al.  Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  M. Raizada,et al.  Insulin Binding in Four Regions of the Developing Rat Brain , 1984, Journal of neurochemistry.

[66]  J. Peña,et al.  Serum gastrin levels during pregnancy. , 1980, Revista espanola de fisiologia.

[67]  P. Insel,et al.  Detection of GPCR mRNA Expression in Primary Cells Via qPCR, Microarrays, and RNA-Sequencing. , 2021, Methods in molecular biology.